Cargando…

A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch

Detalles Bibliográficos
Autores principales: Fokkens, Wytske, Hellings, Peter, Mullol, Joaquim, Munzel, Ullrich, Bachert, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493484/
http://dx.doi.org/10.1186/2045-7022-5-S4-P33
_version_ 1782379924782317568
author Fokkens, Wytske
Hellings, Peter
Mullol, Joaquim
Munzel, Ullrich
Bachert, Claus
author_facet Fokkens, Wytske
Hellings, Peter
Mullol, Joaquim
Munzel, Ullrich
Bachert, Claus
author_sort Fokkens, Wytske
collection PubMed
description
format Online
Article
Text
id pubmed-4493484
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44934842015-07-15 A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch Fokkens, Wytske Hellings, Peter Mullol, Joaquim Munzel, Ullrich Bachert, Claus Clin Transl Allergy Poster Presentation BioMed Central 2015-06-26 /pmc/articles/PMC4493484/ http://dx.doi.org/10.1186/2045-7022-5-S4-P33 Text en Copyright © 2015 Fokkens et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Fokkens, Wytske
Hellings, Peter
Mullol, Joaquim
Munzel, Ullrich
Bachert, Claus
A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
title A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
title_full A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
title_fullStr A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
title_full_unstemmed A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
title_short A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
title_sort new allergic rhinitis therapy (mp29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493484/
http://dx.doi.org/10.1186/2045-7022-5-S4-P33
work_keys_str_mv AT fokkenswytske anewallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch
AT hellingspeter anewallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch
AT mulloljoaquim anewallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch
AT munzelullrich anewallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch
AT bachertclaus anewallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch
AT fokkenswytske newallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch
AT hellingspeter newallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch
AT mulloljoaquim newallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch
AT munzelullrich newallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch
AT bachertclaus newallergicrhinitistherapymp2902provideseffectiveandrapidsymptomreliefforpatientswhosuffermostfromthebothersomesymptomsofnasalcongestionorocularitch